Clinical Trial Update: Aromatase Inhibitors or GnRH-a for Uterine Adenomyosis [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial comparing aromatase inhibitors vs. GnRH agonists for premenopausal women with uterine adenomyosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenomyosis

Drugs mentioned

• Aromatase inhibitor (class)
• Gonadotropin-releasing hormone agonist (class)

Snippet

Sponsor: Mansoura University | Conditions: the Efficacy of Aromatase Inhibitor vs. Gonadotrpins Releasing Hormone Agonists in Treating Premenopausal Women With Uterine Adenomyosis | Phase 2, Phase 3 | Status: COMPLETED